Neonatal cholestasis: development of a diagnostic decision algorithm from multivariate predictive models
- 1 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 180 (5), 1477-1486
- https://doi.org/10.1007/s00431-020-03886-z
Abstract
Despite the recent advances involving molecular studies, the neonatal cholestasis (NC) diagnosis still relays on the expertise of medical teams. Our aim was to develop models of etiological diagnosis and unfavourable prognosis which may support a rationale diagnostic approach. We retrospectively analysed 154 patients born between January 1985 and October 2019. The cohort was divided into two main groups: (A) transient cholestasis and (B) other diagnosis (with subgroups) and also in two groups of outcomes: (I) unfavourable and (II) favourable. Multivariate logistic regression analysis identified the lower gestational age as the only variable independently associated with an increased risk of transient cholestasis and signs and/or symptoms of sepsis with infectious or metabolic diseases. Gamma-glutamyl transferase serum levels > 300 IU/L had a positive predictive value for both diagnosis of biliary atresia and for alpha-1-antitrypsin deficiency (A1ATD) and for unfavourable prognosis. A model of diagnosis for A1ATD (n = 34) showed an area under the ROC curve = 0.843 [confidence interval (CI): 0.773-0.912]. Conclusion: This study identified some predictors of diagnosis and prognosis which helped to build a diagnostic decision algorithm. The unusually large subgroup of patients with A1ATD in this cohort emphasizes its predictive diagnostic model. What Is Known center dot The etiological diagnosis of neonatal cholestasis (NC) requires a step-by-step guided approach, and diagnostic models have been developed only for biliary atresia. center dot Current algorithms neither address the epidemiology changes nor the application of the new molecular diagnostic tools. What Is New center dot This study provides diagnostic predictive models for patients with A1ATD, metabolic/infectious diseases, and transient cholestasis, and two models of unfavourable prognosis for NC. center dot A diagnostic decision algorithm is proposed based on this study, authors expertise and the literature.Keywords
This publication has 27 references indexed in Scilit:
- Neonatal Cholestasis Over Time: Changes in Epidemiology and Outcome in a Cohort of 154 Patients From a Portuguese Tertiary CenterFrontiers in Pediatrics, 2020
- Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation SequencingThe Journal of Pediatrics, 2019
- Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese PatientsEBioMedicine, 2018
- The Third Revolution in Sequencing TechnologyTrends in Genetics, 2018
- Initial assessment of the infant with neonatal cholestasis—Is this biliary atresia?PLOS ONE, 2017
- Guideline for the Evaluation of Cholestatic Jaundice in InfantsJournal of Pediatric Gastroenterology and Nutrition, 2017
- Molecular Genetic Dissection and Neonatal/Infantile Intrahepatic Cholestasis Using Targeted Next-Generation SequencingThe Journal of Pediatrics, 2016
- Ultrasonographic Diagnosis of Biliary Atresia Based on a Decision-Making Tree ModelKorean Journal of Radiology, 2015
- Diversity of Disorders Causing Neonatal Cholestasis – The Experience of a Tertiary Pediatric Center in GermanyFrontiers in Pediatrics, 2014
- Transient neonatal cholestasis: Origin and outcomeThe Journal of Pediatrics, 1998